Evidence map›Paper›PMID 34126764›Full record

ArticlemBio2021

Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response.

Whitney N Wood, Kyle Mohler, Jesse Rinehart, Michael Ibba

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. In the shadow of antibiotics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  7. Article
  8. Article
  9. Ribosome biogenesis in disease: new players and therapeutic targets.Signal transduction and targeted therapy · 2023
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Whitney N WoodDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Kyle MohlerDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, USA.
Jesse RinehartDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, USA.
Michael IbbaDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Yale University · USChapman University · USThe Ohio State University · US

Funding

Investigating mechanisms of kinase-mediated cell migration in aggressive glioblastomaF32CA224946 · NCI · YALE UNIVERSITY · PI MOHLER, KYLE P. · 2018 to 2020
$185k
NCI NIH HHS F32 CA224946
6 · The paper itself

Abstract

Bacterial antibiotic persistence occurs when bacteria are treated with an antibiotic and the majority of the population rapidly dies off, but a small subpopulation enters into a dormant, persistent state and evades death. Diverse pathways leading to nucleoside triphosphate (NTP) depletion and restricted translation have been implicated in persistence, suggesting alternative redundant routes may exist to initiate persister formation. To investigate the molecular mechanism of one such pathway, functional variants of an essential component of translation (phenylalanyl-tRNA synthetase [PheRS]) were used to study the effects of quality control on antibiotic persistence. Upon amino acid limitation, elevated PheRS quality control led to significant decreases in aminoacylated tRNA

Indexed as

Drug Resistance, BacterialAmino AcidsAnti-Bacterial AgentsEscherichia coliEscherichia coli ProteinsMicrobial ViabilityPhenylalanine-tRNA LigaseRNA, TransferTransfer RNA AminoacylationAmino AcidsAnti-Bacterial AgentsEscherichia coli ProteinsPhenylalanine-tRNA LigaseRNA, TransferpersistencetranslationtRNA

Identifiers

PMID34126764
PMCPMC8262941
OpenAlexW3169648013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.